Device Trial Radar · NCT05400980
Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath
Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Jul 5, 2022
Primary completion
Jan 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Prodeon Medical, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 2, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate the safety and efficacy of the Urocross Expander System/Retrieval Sheath and the procedure to treat patients with symptomatic Benign Prostatic Hyperplasia (BPH).
Conditions
- Benign Prostatic Hyperplasia
Interventions
Urocross implantDevice
Urocross implant inserted via delivery catheter
Sham-controlDiagnostic test
Cystoscopy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of Urocross Expander ImplantTime frame: more than 7 days post procedure
- Efficacy of the Urocross Expander Implant as delivered by the Urocross Expander System and the Urocross Retrieval SheathTime frame: 3 months post-procedure
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Loyola University Medical Center
Maywood, Illinois
Virginia Tech-Carilion School of Medicine
Roanoke, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.